Home/Filings/4/0001104659-21-075235
4//SEC Filing

Roche Corleen M. 4

Accession 0001104659-21-075235

CIK 0001472012other

Filed

May 31, 8:00 PM ET

Accepted

Jun 1, 7:21 PM ET

Size

5.4 KB

Accession

0001104659-21-075235

Insider Transaction Report

Form 4
Period: 2021-05-28
Roche Corleen M.
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-05-28+16,60916,609 total
    Exercise: $20.92Exp: 2031-05-28Common Stock (16,609 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option vest on May 28, 2022, and one-thirty-sixth (1/36th) of the remaining shares subject to the option shall vest every month thereafter.

Issuer

Immunome Inc.

CIK 0001472012

Entity typeother

Related Parties

1
  • filerCIK 0001857905

Filing Metadata

Form type
4
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 7:21 PM ET
Size
5.4 KB